RSSMicro.com Search - RSS Feed Search Engine - RSS Feed Directory
Dedicated RSS Feed Search Engine
 Search 2.1 million RSS feeds
The most comprehensive RSS feed search on the web
Top Stories  |  FeedRank Checker

Published

   Last Hour

   Last Day

   Past Week

   Past Month

 Anytime







Featured
RSS Feeds


CNN RSS Feeds

Reuters RSS Feeds

MSNBC RSS Feeds

New York Times RSS Feeds

Washington Post RSS Feeds

CNBC RSS Feeds

ABC News RSS Feeds

Fox News RSS Feeds

Sky News RSS Feeds

Forbes RSS Feeds

CNET RSS Feeds

Unicef RSS Feeds

PBS RSS Feeds

Wall Street Journal RSS Feeds

Financial Times RSS Feeds

Business Week RSS Feeds

Bloomberg RSS Feeds

TheStreet RSS Feeds

ESPN RSS Feeds

   


Calculate your site FeedRank Today

FeedRank - RSSMicro Search

FeedRank, a newly developed algorithm for ranking RSS feeds only on RSSMicro
Click here to learn more




FeedRank: 4/10  4/10  Good  ---  feeds.portfolio.com
A smart take on the day's business headlines with insightful commentary and a sense of humor. ...

 

 
Tuesday, May 13, 2008 --- 73 days ago
When IVAX Corp. chairman and chief executive Phillip Frost named Zachariah P. Zachariah to his company's board, he trumpeted the new director's "great knowledge and experience." Zachariah did have several decades of experience as a cardiologist, something from which a specialty pharmaceuticals company like IVAX could truly benefit. Unfortunately, according to federal regulators, Zachariah had experience at something else, and it has come back to bite IVAX and its new owner, Teva Pharmaceuticals. The Securities and Exchange Commission today sued Zachariah, accusing him of trading on insider information that he obtained as an IVAX director about two months after he joined the board. At the same time, the S.E.C. accused Zachariah — a political appointee of both President Bush and his brother, former Governor Jeb Bush of Florida — of having engaged in insider trading in shares of another company where he worked as a consultant, Correctional Services Corp. In the IVAX matter, the S.E.C. says that Frost called Zachariah and other IVAX directors on July 6, 2005, after reaching a deal to sell the company to Teva. Although he was forbidden to trade on the information, Zachariah started doing so "within minutes" of hanging up, the commission contends. Over time, Zachariah bought 35,000 shares of IVAX stock at an average cost of about $20.86 a share. Teva offered to buy IVAX for $26 a share, netting Zachariah a quick ...




Recent Posts





 Facebook     Del.icio.us     Digg     StumbleUpon     Reddit     Google
Copyright © 2008 RSSMicro.com